We are proud to announce that we have joined the Drug Science Enhanced Harm Reduction working group. The consortium of scientific experts, academics, policy makers, treatment providers and advocacy groups, are working collaboratively to reduce the harms of intravenous drug use. The main aim of the group is to develop the evidence base for reducing drug-related harm by piloting a Supervised Injection Facility (SIF) in the UK.

Our Campaigns and Communications Lead, Rob Barker, will be representing Barod within the working group. Rob has extensive knowledge regarding Supervised Injecting Facilities, having undertaken a Churchill Fellowship back in 2017, that took him across North America and Europe, aiming to understand the policies and procedures of setting up such facilities. Since then Rob has been an active member of, and chaired, the Wales Enhanced Harm Reduction Centre’s multidisciplinary group.

We look forward to working with new and existing partners within this working group. To find out more about Drug Science, their work and the Enhanced Harm Reduction Working group, click here.